UID:
almahu_9948025733102882
Format:
1 online resource (665 p.)
Edition:
5th ed.
ISBN:
1-281-02902-5
,
9786611029029
,
0-08-052583-0
Content:
For twenty years this book, now in its 5th edition, has provided information on adverse drug interactions that is unrivalled in coverage and scholarship. Adverse drug reactions, many of them ascribable to interactions with other drugs or with chemical substances in food or the environment, are thought to cause or complicate one in twenty of hospital admissions. The book is conveniently divided into two parts: Part 1 comments on drug interactions and their mechanisms, on a pharmacokinetic and pharmacodynamic level, while Part 2 consists of drug interaction tables, divided and subdivided
Note:
Description based upon print version of record.
,
Front Cover; A Manual of Adverse Drug Interactions; Copyright Page; Foreword; Preface; Acknowledgements; Contents; Part 1. Commentary on Drug Interactions and their Mechanisms; Introduction: A widening problem; A. Pharmacokinetic drug interactions; B . Pharmacodynamic drug interactions; References to Part 1; Part 2. Drug Interaction Tables; Chapter 1. Drug interactions with agents used to treat gastrointestinal disease; Section I. Interactions with agents used to treat peptic ulceration and other gastrointestinal disorders; Section II. Drugs affecting gastrointestinal motility
,
Section III. Drugs used to treat inflammatory bowel diseasesChapter 2. Drug interactions with agents used in the treatment of cardiovascular disease; 2.1. Interactions with cardiac drugs; 2.2. Interactions with drugs used to treat hypertension; 2.3. Drugs interactions with anticoagulants and fibrinolytic agents; 2.4. Drug interactions with lipid lowering agents; 2.5. Diuretics; Chapter 3. Drug interactions with agents used in respiratory disease; 3.1. Interactions with sympathomimetic amines; 3.2. Interactions with theophylline and derivatives; 3.3. Antihistamines
,
Chapter 4. Drug interactions with agents used in the treatment of CNS disorders4.1. Interactions with drugs used in the treatment of schizophrenia and related psychoses; 4.2. Interactions with drugs used in the treatment of depressive illness; 4.3. Drug interactions with lithium salts; 4.4. Agents used in the treatment of epilepsy; 4.5. Interactions with drugs used in the treatment of parkinsonism; Chapter 5. Drug interactions with antimicrobial agents; 5.1. Aminoglycosides; 5.2. Cephalosporins and related β-lactam antibiotics; 5.3. Chloramphenicol and thiamphenicol; 5.4. Clindamycin
,
5.5. Fusidic acid5.6. Glycopeptide antibiotics; 5.7. Imidazole antibacterials; 5.8. Macrolide antibiotics; 5.9. Nitrofurans; 5.10. Penicillins; 5.11. Polymyxins; 5.12. 4-Quinolones; 5.13. Sulphonamides; 5.14. Tetracyclines; 5.15. Trimethoprim; 5.16. Antituberculous agents; 5.17. Antifungal agents; 5.18. Antiviral agents; Chapter 6. Drug interactions with agents used to treat endocrine disorders; 6.1. Drugs used in diabetes; 6.2. Interactions with corticosteroids; 6.3. Interactions with drugs used in the treatment and prevention of osteoporosis
,
Chapter 7. Drug interactions with oral contraceptivesChapter 8. Drug interactions with agents used in immunosuppression and cancer chemotherapy; 8.1. Drug interactions with immunosuppressants; 8.2. Drug interactions with antineoplastic agents; Chapter 9. Drug interactions with aspirin and other non-steroidal anti-inflammatory agents; 9.1. Aspirin; 9.2. Other NSAIDs; Chapter 10. Drug interactions with vaccines and interferons; Chapter 11. Drug interactions with agents used in anaesthesia; 11.1. Drug interactions with local anaesthetics; 11.2. Skeletal muscle relaxants
,
Chapter 12. Drug interactions with herbal remedies
,
English
Additional Edition:
ISBN 0-444-82406-5
Language:
English
